The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3495-3504

  Dong, Gang ^a   Chen, Zhong ^a   Kato, Taiji ^a   Van Waes, Carter ^a,b  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b Developmental Neuroscience Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYTOKINES; CYTOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEASE INHIBITORS; PYRROLIDINES; RECOMBINANT FUSION PROTEINS; SELECTION (GENETICS); THIOCARBAMATES; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR RELA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033565516     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Chen, Z., Colon, I., Ortiz, N., Callister, M., Dong, G., Pegram, M. Y., Arosarena, O., Strome, S., and Van Waes, C. Effects of IL-1α, IL-IRA and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res., 58: 3668-3676, 1998.
2. Woods, K. V., El-Naggar, A., Clayman, G. L., Grimm, E. A. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res., 58: 3132-3141, 1998.
3. Mann, E., Spiro, J., Chen, L., and Kreutzer, D. Cytokine expression by head and neck squamous cell carcinoma. Am. J. Surg., 164: 567-573, 1992.
4. Cohen, R., Contrino, J., Spiro, J., Mann, E., Chen, L., and Kreutzer, D. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 121: 202-209, 1995.
5. Young, M. R. I., Wright, M. A., Lozano, Y., Prechel, M. M., Benefield, J., Leonetti, J. P., Collins, S. L., and Petruzelli, G. J. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony stimulating factor and contained CD34+ natural suppressor cells. Int. J. Cancer, 74: 69-74, 1997.
6. Yamamura, M., Modlin, R., Ohmen, J., and Moy, R. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest., 91: 1005-1010, 1993.
7. Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I., Yeh, N. T., Kroog, G. S., Rudy, S., McCullagh, L., Mousa, S., and Van Waes, C. Expression of proinflammatory and proangiogenic cytokines in human head and neck cancer patients. Clin. Cancer Res. 5: in press, 1999.
8. Oka, M., Yamamoto, K., Takahashi, M., Hakozaki, M., Abe, T., Iizka, N., Hazama, S., Hirazawa, K., Hayashi, H., Tangoku, A., Hirose, K., Ishihara, T., and Suzuki, T. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res., 56: 2776-2780, 1996.
9. Ueda, T., Shimada, E., and Urakawa, T. Serum levels cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J. Gastroenterol., 29: 423-429, 1994.
10. Scheibenbogen, C., Mohler, T., Haefele, J., Hunstein, W., and Keilholz, U. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res., 5: 179-181, 1995.
11. Woodworth, C. D., Mcmullin, E., Iglesias, M., and Plowman, G. D. Interleukin 1 α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc. Natl. Acad. Sci. USA, 92: 2840-2844, 1995.
12. Iglesias, M., Plowman, G. D., and Woodworth, C. D. Interleukin-6 and interleukin 6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. Am. J. Pathol., 146: 944-952, 1995.
13. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151: 2667-2675, 1993.
14. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., and Stricter, R. M. Inhibition of IL-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest., 97: 2792-2802, 1996.
15. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
16. Smith, C. W., Chen, Z., Dong, G., Loukinova, E., and Van Waes, C. The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1α, IL-6, GM-CSF and KC. Clin. Exp. Metastasis, 16: 655-664, 1998.
17. Chen, Z., Smith, C. W., Kiel, D., and Van Waes, C. Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin. Exp. Metastasis, 15: 527-537, 1997.
18. Yuspa, S. H., Hawley-Nelson, P., Koehler, B., and Stanley, J. R. A survey of transformation markers in differentiating epidermal cell lines. Cancer Res., 40: 4694-4703, 1980.
19. Akira, S., and Kishimoto, T. NF-IL6 and NF-κB in cytokine gene regulation. Adv. Immunol., 65: 1-45, 1997.
20. Baeuerle, P. A. Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr. Biol., 8: R19-R22, 1998.
21. Baldwin, A., Jr. The NF-kB, and IkB proteins: new discoveries and insights. Annu. Rev. Immunol., 14: 649-683, 1996.
22. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. W. Rel/NFkB/IkB proteins and cancer. Oncogene, 13: 1367-1378, 1996.
23. Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., and Baldwin, A. S. Requirement of NF-κB activation to suppress p-53 independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.
24. Wang, C-Y, Mayo, M. W., and Baldwin, A. S., Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
25. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Washington DC), 274: 787-789, 1996.
26. Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., and Baltimore, D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Gene Dev., 7: 1354-1363, 1993.
27. Oquendo, P., Alberta, J., Wen, D., Graycar, J. L., Derynck, R., and Stiles, C. D. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet α-granule proteins. J. Biol. Chem., 264: 4133-4137, 1989.
28. Brown, K., Franzoso, G., Baldi, L., Carlson, L., Mills, L., Lin, Y. C., Gerstberger, S., and Siebenlist, U. The signal response of IκBα is regulated by transferable N-and C-terminal domains. Mol. Cell. Biol., 17: 3021-3027, 1997.
29. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
30. Beg, A. A., Finco, T. S., Nantermet, P. V., and Baldwin, A. S. Tumor necrosis factor and IL-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol., 13: 3301-3310, 1993.
31. Dong, G., Broker, T. R., and Chow, L. T. Human papilloma type 11E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol., 68: 1115-1127, 1994.
32. Harlow, E., and Lane, D. Antibodies, a Laboratory Manual, pp. 376-420. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
33. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning, a Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
34. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M. Ben-Niriah, Y., and Baeuerle, P. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (Lond.), 365: 182-185, 1993.
35. Miyamoto, S., Chiao, P., and Verma, I. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature B-cell lines. Mol. Cell. Biol., 14: 3276-3282, 1994.
36. Schreck, R., Meier, B., Mannel, D., Droge, W., and Baeuerle, P. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med., 175: 1181-1194, 1992.
37. Duffey, D., Ondrey, F. G., Chen, Z., Dong, G., and Van Waes, C. Activation of immediate-early transcription factor NF-κB in human head and neck squamous carcinoma cell lines that are resistant to TNF α. Proc. Am. Assoc. Cancer Res., 39: 451, 1998.
38. Wood, L. D., and Richmond, A. Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/Groα gene requires both NF-κB and novel constitutive factors. J. Biol. Chem., 270: 30619-30626, 1995.
39. Bhat-Nakshatri, P., Newton, T., Goulet, R., and Nakshatri, H. NF-κB activation and IL-6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived IL-1α. Proc. Natl. Acad. Sci. USA, 95: 6971-6976, 1998.
40. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997.
41. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., and Traish, A. M. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100: 2952-2960, 1997.
42. Shattuck-Brandt, R. L., and Richmond, A. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res., 57: 3032-3039, 1997.
43. Li, J-J., Westergaard, C., Ghosh, P., and Colburn, N. H. Inhibition of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57: 3569-3576, 1997.
44. Li, J-J., Rhim, J. S., Schlegel, R., Vousden K. H., and Colburn, N. H. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene, 16: 2711-2722, 1998.
45. Wang, W., Larry, L., Evans, D. B., Abbruzzese, J. L., Boyd, D., and Chiao, P. J. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated Rel A. Proc. Am. Assoc. Cancer Res., 39: 48, 1998.
46. Cadoret, A., Bertrand, F., Baron-Delage, S., Levy, P., Courtois, G., Gespach, C., Capeau, J., Cherqui, G. Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. Oncogene, 14: 1589-1600, 1997.
47. Higgins, K. A., Perez, J. R., Coleman T. A., Dorshkind, K., McComas, W. A., Sarmiento, U. M., Rosen, C. A., and Narayanan, R. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and cause tumor regression. Proc. Natl. Acad. Sci. USA, 90: 9901-9905, 1993.
48. Kato, T., Duffey, D., Ondrey, F. G., Chen, Z., Dong, G., Cook, J. A., Michell, J. B., and Van Waes, C. Activation of NF-κB is a better predictor to detect the radiosensitivity in human head and neck squamous cell carcinoma. Proc. Am. Assoc. Cancer Res., 39: 383, 1998.
49. Jung, M., Zhang, Y., Lee, S., and Dritschilo, A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IkB-a. Science (Washington DC), 268: 1619-1621, 1995.
50. Yamagish, N., Miyakoshi, J., and Takebe, H. Enhanced radiosensitivity by inhibition of nuclear factor κB activation in human malignant gloma cells. Int. J. Radiat. Biol., 72: 157-162, 1997.
51. Jobin, C., Haskill, S., Mayer, L., Panjia, A., and Sartor, R. B. Evidence for altered regulation of IκBα degradation in human colonie epithelial cells. J. Immunol., 158: 226-234, 1997.
52. Phillips, R., and Ghosh, S. Regulation of IκBβ in WEHI 231 mature B cells. Mol. Cell. Biol., 17: 4390-4396, 1997.
53. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M. G., and Packer, L. Redox regulation of NF-κB activation. Free Radical Biol. Med., 22: 1115-1126, 1997.
54. Fino, T. S., Beg, A. A., and Baldwin, A. S. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA, 91: 11884-11888, 1994.
55. Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J. D., Stricter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K. N., and Richmond, A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukocyte Biol., 62: 588-597, 1997.
56. Wood, L. D., Farmer, A. A., and Richmond, A. HMGI(Y) and sp1 in addition to NF-κB regulate transcription of the MGSA/GROα gene. Nucleic Acids Res., 23: 4210-4219, 1995.
57. Ohmori, Y., Fukumoto, S., and Hamilton, T. A. Two structurally distinct κB sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol., 155: 3593-3600, 1995.